Abstract:Background: An increasing number of centers are undertaking combined heart and liver transplantation in adult and pediatric patients with congenital heart disease. Aim: The primary aim of this study was to describe the perioperative management of a single center cohort, identifying challenges and potential solutions. Methods: We conducted a retrospective review of all patients undergoing combined heart and liver transplantation at Stanford Children's Hospital from 2006 to 2022. Preoperative information included cardiac diagnosis, hemodynamics, and severity of liver disease. Intraoperative data included length of surgery, cardiopulmonary bypass time, and blood products transfused. Postoperative data included blood products transfused in the intensive care unit, time to extubation, length of intensive care unit stay, survival outcomes and 30-day adverse events. Results: Eighteen patients underwent en bloc combined heart and liver transplantation at Stanford Children's Hospital from 2006 to 2022, and the majority 15 (83%) were transplanted for failing Fontan circulation with Fontan Associated Liver Disease. Median surgical procedure time was 13.4 [11.5, 14.5] h with a cardiopulmonary bypass time of 4.3 [3.9, 5.8] h. Median total blood products transfused in the operating room post cardiopulmonary bypass was 89.4 [63.9, 127.0] mLs/kg. Nine patients (50%) had vasoplegia during cardiopulmonary bypass. Activated prothrombin complex concentrates were used post cardiopulmonary bypass in 15 (83%) patients with a 30-day thromboembolism rate of 22%. Median time to extubation was 4.0 [2.8, 6.5] days, median intensive care unit length of stay 20.0 [7.8, 48.3] days and median hospital length of stay 54.0 [30.5, 68.3] days. Incidence of renal replacement therapy was 11%; however, none required renal replacement therapy by the time of hospital discharge. Neurological events within 30 days were 17% and the 30 day and 1 year survival was 89%. Conclusions: Perioperative challenges include major perioperative bleeding, unstable hemodynamics, and end organ injury including acute kidney injury and neurological events. Successful outcomes for en bloc combined heart and liver transplantation are possible with careful multidisciplinary planning, communication, patient selection, and integrated peri-operative management.

Triple-Organ Transplantation: Dual Heart-Kidney Transplantation After Lung Transplantation

Incidence and Outcomes of Simultaneous Thoracoabdominal Triple Organ Transplantation in the United States

Combined Liver-Lung-Kidney Transplant in a Patient with Cystic Fibrosis

Combined Heart and Kidney Transplantation from the Same Donor As Treatment for End-Stage Heart and Renal Failure (report of One Case)

Perioperative management of simultaneous liver,pancreas-duodenum and kidney transplantation

Perioperative Management of Multiorgan Transplantation

Combined Organ Transplantation in Patients with Advanced Liver Disease

First lung and kidney multi-organ transplant following COVID-19 Infection

Perioperative Management of Pediatric Combined Heart and Liver Transplantation: A 17 year single center experience

Combined Heart and Kidney Transplantation: Initial Clinical Experience

A 14-Year Follow-Up of a Combined Liver-Pancreas-Kidney Transplantation: Case Report and Literature Review.

Pediatric Combined Heart-liver Transplantation: A Single-center Long-term Experience

Successful Treatment of Multi-Drug Resistant Tuberculosis by Double Lung Transplantation

Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancer

Experience of Combined Heart-lung Transplantation for 2 Eisenmenger′s Syndrome Patients

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Uremia, and Insulin-Dependent Diabetes

Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States

Bridge to second double lung transplant with an extracorporeal carbon dioxide removal system in situs inversus patient

Two Cases of Combined Liver-Kidney Transplantation.

Four Decades of Progress in Heart-Lung Transplantation: 271 Cases at a Single Institution.

Contemporary Immunosuppression Management and 1-Year Outcomes in Dual Organ Heart Transplantation